BRIEF published on 12/05/2025 at 00:10, 4 hours 24 minutes ago Launch of a Capital Increase by CFI Euronext Paris Capital Increase Preferential Subscription Right CFI Apsys Financial
BRIEF published on 10/01/2025 at 11:35, 2 months 3 days ago Availability of CFI's half-yearly financial report Investors Half-yearly Report Regulated Information CFI Finances 2025
BRIEF published on 06/06/2025 at 18:50, 5 months 28 days ago CFI: Preparatory documents for the General Assembly available Paris Annual Report General Meeting Preparatory Documents CFI
BRIEF published on 10/03/2024 at 21:40, 1 year 2 months ago CFI Publishes its 2024 Half-Yearly Financial Report Investors Financial Report 2024 Financial Markets CFI
BRIEF published on 05/01/2024 at 12:50, 1 year 7 months ago CFI 2023 Annual Financial Report Now Available Investors Financial Report 2023 Financial Markets CFI
Published on 12/05/2025 at 02:35, 1 hour 59 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 3 hours 34 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 5 hours 29 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 5 hours 34 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 1 hour 3 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 4 hours 43 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 8 hours 8 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 8 hours 18 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 9 hours 23 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:00, 10 hours 34 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 10 hours 49 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 10 hours 49 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 21 hours 33 minutes ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 10 hours ago Declaration of voting rights at the end of November 2025
